GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of PDE10A complexed with 3- (1-phenyl-1H-pyrazol-5-yl)-1-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDAZIN- 4(1H)-one

Analyse Crystal structure of the catalytic domain of PDE10A complexed with 3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3WYK
Type
protein
Length
630 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A
EC
3.1.4.17, 3.1.4.35
UniProt
Q9Y233
Ligands
3KG, MG, ZN
Pockets
7 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17, 3.1.4.35)protein31572% helix, 0% strandQ9Y233

Ligands and binding sites

  • 3KG · 3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethyl)phenyl]pyridazin-4(1H)-one · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14350.730.8347MG, 3KG
25640.730.8156MG, 3KG
37240.710.7764empty
4530.520.8821empty
5740.350.7617empty

Interfaces

1 interface between chains.

  • A–B · 801 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 3WYK · Crystal structure of the catalytic domain of PDE10A complexed with… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.